it is not clear if they're getting on top of the problems in the mill. There is no certainty they have the management to overcome these issues. We need some stable production figures and costs, otherwise we are investing on hope.
Management have been opaque on crucial information to further invest. Like it's sister company DNK, it's dropped too low to sell and we may need to put them into the bottom drawer and hope for capable management to take over before it goes pear shaped.
- Forums
- ASX - By Stock
- E25
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
E25
element 25 limited
Add to My Watchlist
4.44%
!
21.5¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-113
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.5¢ |
Change
-0.010(4.44%) |
Mkt cap ! $49.15M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $7.969K | 36.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 27140 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 28341 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 27140 | 0.215 |
3 | 70690 | 0.210 |
4 | 339200 | 0.205 |
9 | 90370 | 0.200 |
4 | 471077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 28341 | 2 |
0.225 | 70231 | 3 |
0.230 | 72958 | 1 |
0.235 | 124800 | 3 |
0.240 | 255584 | 3 |
Last trade - 12.45pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online